BIOARRAY Genetics Inc. Announces the Launch of a Novel Oncology Gene Panel

BIOARRAY Genetics Inc. announced the launch of a novel oncology gene panel, BA325, a research and development tool that accelerates drug discovery and development for cancer treatments by providing new information on cancer response to treatments. BA325 contains 32 genes that are currently drug treatment targets, and provides comprehensive information about oncology drug sensitivity and resistance.

Read full article here

2018-04-26T20:49:36+00:00